EUVIMED · CrossrefJournal
Clinical Schizophrenia & Related Psychoses
ISSN 1935-1232 · Longdom Group
Latest articles
Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder
Prevalence and clinical impact of childhood adversities in women with schizophrenia
Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia
Psychosis as a sequelae of paraneoplastic syndrome in Small- Cell Lung Carcinoma: A psycho-neuroendocrine interface
Adherence to Diabetes Medication in Individuals with Schizophrenia: A Systematic Review of Rates and Determinants of Adherence
C-Reactive Protein Levels in Schizophrenia
Combining Computerized Social Cognitive Training with Neuroplasticity-Based Auditory Training in Schizophrenia
New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia
Clozapine
Lurasidone for the Acute Treatment of Adults with Schizophrenia: What is the Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed?
Placebo-Controlled Trial of Atomoxetine for Weight Reduction in People with Schizophrenia Treated with Clozapine or Olanzapine
Trajectories of Social Withdrawal and Cognitive Decline in the Schizophrenia Prodrome
Elderly Patients with Schizophrenia and Depression: Diagnosis and Treatment
Stressful Life Events, Social Class and Symptoms of Schizophrenia
Cariprazine for the Treatment of Schizophrenia: A Review of this Dopamine D3-Preferring D3/D2 Receptor Partial Agonist
Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient
Clinical News
Highlights from the 2016 Schizophrenia International Research Society Conference, April 2–6, 2016
Anxiety Symptoms in Psychotic Disorders: Results from the Second Australian National Mental Health Survey
Clinical News
Emotional, Cognitive and Behavioral Reactions to Paranoid Symptoms in Clinical and Nonclinical Populations
Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder
A Review of the Impact of Exclusion Criteria on the Generalizability of Schizophrenia Treatment Research
Turner Mosaicism and Schizoaffective Disorder: The First Reported Case
Folie à Deux in Monozygotic Twins with Cerebral Palsy
Clinical News
The Development and Implementation of an Electronic Health Record Tool for Monitoring Metabolic Syndrome Indices in Patients with Serious Mental Illness
Efficacy of the Social Cognition Training Program in a Sample of Outpatients with Schizophrenia
Guide to the Management of Clozapine-Related Tolerability and Safety Concerns
Psychotic Disorder in Neurodegeneration with Brain Iron Accumulation
EUVIMED